| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S2215-0366(15)00308-9 |
| P698 | PubMed publication ID | 26521769 |
| P50 | author | Philip McGuire | Q37834611 |
| Rodrigo A. Bressan | Q39051055 | ||
| P2093 | author name string | Andrea Mechelli | |
| Andrea Jackowski | |||
| Joao R Sato | |||
| Andre Zugman | |||
| P2860 | cites work | Neuropsychosocial profiles of current and future adolescent alcohol misusers | Q24289323 |
| Translating the MAM model of psychosis to humans | Q26860217 | ||
| Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation | Q27320072 | ||
| Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis | Q28237307 | ||
| Machine learning classifiers and fMRI: a tutorial overview | Q28310323 | ||
| Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring | Q28754716 | ||
| Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition | Q30432820 | ||
| Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals | Q30447851 | ||
| Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification | Q30447856 | ||
| Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis | Q30450082 | ||
| Using genetic, cognitive and multi-modal neuroimaging data to identify ultra-high-risk and first-episode psychosis at the individual level | Q30603105 | ||
| An empirical comparison of different approaches for combining multimodal neuroimaging data with support vector machine | Q30839607 | ||
| Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study | Q31152078 | ||
| Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders | Q33555684 | ||
| Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis | Q33636892 | ||
| Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations | Q33762566 | ||
| The hubs of the human connectome are generally implicated in the anatomy of brain disorders | Q33937468 | ||
| The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. | Q34065449 | ||
| Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms | Q34153146 | ||
| Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. | Q34174069 | ||
| Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis | Q34270086 | ||
| Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America | Q34586836 | ||
| Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial | Q34616402 | ||
| Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk | Q34636460 | ||
| Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk | Q34691699 | ||
| Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers | Q35096522 | ||
| Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial | Q36386323 | ||
| Alterations in white matter evident before the onset of psychosis. | Q36386344 | ||
| Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study | Q36386359 | ||
| North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment | Q36412920 | ||
| Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study | Q36928703 | ||
| Using structural neuroimaging to make quantitative predictions of symptom progression in individuals at ultra-high risk for psychosis | Q37526460 | ||
| Intervention in individuals at ultra-high risk for psychosis: a review and future directions | Q37539071 | ||
| Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. | Q37981419 | ||
| Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis | Q42967481 | ||
| Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study | Q42984373 | ||
| Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study | Q43851337 | ||
| Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study | Q43987270 | ||
| Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images. | Q45961178 | ||
| White-matter markers for psychosis in a prospective ultra-high-risk cohort | Q46082587 | ||
| Elevated striatal dopamine function linked to prodromal signs of schizophrenia | Q46174418 | ||
| Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis | Q46762892 | ||
| Psychiatry beyond the current paradigm | Q48268122 | ||
| Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. | Q48303697 | ||
| Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis | Q48394255 | ||
| Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples | Q48565958 | ||
| Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? | Q50747047 | ||
| Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. | Q50803831 | ||
| Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis. | Q51032268 | ||
| Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. | Q51886500 | ||
| Can antidepressants prevent psychosis? | Q57519894 | ||
| Disordered functional connectivity in schizophrenia1 | Q60242723 | ||
| Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents | Q80254635 | ||
| P433 | issue | 12 | |
| P921 | main subject | psychosis | Q170082 |
| neuroimaging | Q551875 | ||
| P304 | page(s) | 1117-1122 | |
| P577 | publication date | 2015-10-27 | |
| P1433 | published in | The Lancet Psychiatry | Q27118886 |
| P1476 | title | Can neuroimaging be used to predict the onset of psychosis? | |
| P478 | volume | 2 |
| Q38759421 | Altering the course of schizophrenia: progress and perspectives |
| Q51767689 | Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders. |
| Q90392652 | Atypical processing of uncertainty in individuals at risk for psychosis |
| Q100737114 | Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis |
| Q47883423 | Crisis in neuroimaging: is neuroimaging failing 15 years after the decade of the brain? |
| Q37711762 | Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study |
| Q99416133 | Dysregulated Lipid Metabolism Precedes Onset of Psychosis |
| Q96133509 | Early magnetic resonance imaging biomarkers of schizophrenia spectrum disorders: Toward a fetal imaging perspective |
| Q48065645 | Predicting treatment outcome in depression: so far, so good. |
| Q92566301 | Progress in psychoradiology, the clinical application of psychiatric neuroimaging |
| Q58740905 | Recognition of Schizophrenia with Regularized Support Vector Machine and Sequential Region of Interest Selection using Structural Magnetic Resonance Imaging |
| Q33777660 | Structural Network Disorganization in Subjects at Clinical High Risk for Psychosis |
| Q36348922 | Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies |
| Q92093093 | Translating research findings into clinical practice: a systematic and critical review of neuroimaging-based clinical tools for brain disorders |
| Q33814290 | Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis. |
Search more.